We're Hiring Menu

Injection intervals in treatment-naive neovascular age-related macular degeneration (nAMD) patients who received anti-vascular endothelial growth factor (VEGF) agents: Intelligent Research in Sight (IRIS®) Registry analysis

Author: Chelsea Phou
October 2019
Back